A rebound tonometer designed for patients to use at home can obtain IOP measurements comparable to Goldmann applanation tonometry (GAT).[Read More …] Source: Daily Dose of Eye Care
https://www.lvcenter4sight.com/home-tonometry-device-correlates-with-gat/
The FDA has approved Icare HOME, a rebound tonometer designed for patients to use at home, offering the ability to track IOP fluctuations throughout the day.[Read More …] Source: Daily Dose of Eye Care
https://www.lvcenter4sight.com/iop-self-monitoring-device-clears-fda/
A new class of therapy that can selectively destroy cancer cells using a light-activated viral nanoparticle has received FDA fast track designation for the treatment of ocular melanoma.[Read More …] Source: Daily Dose of Eye Care
https://www.lvcenter4sight.com/fda-fast-tracks-ocular-melanoma-treatment/
Telemedicine in an urban setting shows significant potential for intervention in the earliest phases of diabetic retinopathy when treatment can prevent vision loss.[Read More …] Source: Daily Dose of Eye Care
https://www.lvcenter4sight.com/non-mydriatic-dr-screening-effective-in-reaching-minority-populations/
An organic retinal prosthesis has restored light perception in blind rats with retinitis pigmentosa, suggesting that restoring sight in humans may soon be possible without the complex hardware required for today s devices.[Read More …] Source: Daily Dose of Eye Care
https://www.lvcenter4sight.com/functional-retinal-prosthesis-created-from-organic-materials/
Scientists have found that the growth factor TGF-beta may play a role in the formation of posterior capsule opacification (PCO), suggesting a new direction for research.[Read More …] Source: Daily Dose of Eye Care
https://www.lvcenter4sight.com/scientists-zero-in-on-pco-cause/
A new dry eye drug that aims to stimulate tear production will advance to phase 1/2 clinical testing this month.[Read More …] Source: Daily Dose of Eye Care
https://www.lvcenter4sight.com/sjogrens-dry-eye-treatment-proceeds-to-human-trials/
